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was 1-4g/ml for pentamycin, 1-2g/ml for nystatin, 0.5-
1g/ml for amphotericin B and 1-32g/ml for ﬂuconazole.
Some strains of C. glabrata and S. cerevisiae, and most
strains of C. krusei were categorized as susceptible-dose
dependent or resistant to ﬂuconazole, according to the CLSI
document (MIC > 8g/ml). At concentrations)4g/ml, pen-
tamycin inhibited completely the growth of 100% of strains
of all species tested, including those strains less susceptible
to ﬂuconazole (MIC range: 16-32g/ml).
Conclusion: Pentamycin exhibited potent in-vitro fungi-
cidal activity against the yeasts that are frequently isolated
in recurrent forms of vaginal mycoses and mixed infections,
like C. glabrata and S. cerevisiae (J. Clin. Microbiol. 43:
2155-62, 2005; Mycoses 49: 471-5, 2006). Pentamycin was
also highly active against the strains of non-albicans candidal
species that were susceptible-dose dependent or resistant to
ﬂuconazole.
doi:10.1016/j.ijid.2010.02.1748
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Background: Mycotic Keratitis is a suppurative, usually
ulcerative, and sight threatening infection of cornea that
sometimes lead to loss of vision. The peak of incidence
is observed in the tropical and subtropical regions. To
investigate the etiological agent, predisposing factors and
treatment follow up of mycotic keratitis; this study was
undertaken over a period of 2 years in Mashhad.
Methods: In this prospective, cross sectional study,
among 466 individuals suffering from keratitis,65 patients,
highly suspected to mycotic keratitis were examined by
direct fresh smear (KOH 10%) and culture in Mycology Media.
The results were analyzed by SPSS method.
Results: Among 65 clinically suspected individuals, the
results of direct smear and culture of 44 patients were pos-
itive. 21 patients were male (47.1%) and 24 were female
(52.3%). The patients were between 8 to 84 years old. More
than 40% of them were farmers. Trauma was the most com-
mon predisposing factors in more than 47% cases due to
vegetable material.
Molds and Yeasts were isolated from 86.4% and 13.6% of
the samples respectively.Fusarium spp. were the most frequent isolates
(44.4%).Others included Aspergillus spp. (21.8%), Acre-
monium spp. (8.3%), Penicillium spp. (5.6%) and Candida
albicans (13.9%).Tearing and redness were the most com-
n
u
ats e119
on symptoms observed (93.2%). Amphotricin B was used
n patients with Aspergillus and Candida Keratitis, but for
usarium and other molds keratitis, Natamycin was used
or 6 to 12 weeks. In one patient with Fusarium Keratitis,
edical therapy was failed and therapeutic penetrating
eratoplasty was performed. Six months follow up showed
hat prognosis was good in all of the patients.
Conclusion: In relation to the last decade, the incidence
f Mycotic Keratitis is increased in Mashhad. Keratitis due to
he molds is more prevalent than yeast keratitis. Entrance
f foreign body (Plant particles) is the most common predis-
osing factor. However, it needs long term therapy but the
rognosis is good.
oi:10.1016/j.ijid.2010.02.1749
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dentiﬁcation of clinically signiﬁcant Mucormycota
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Background: Mucormycosis is a frequently lethal invasive
nfection in high risk individuals including transplant recip-
ents and diabetic individuals. Members of these taxa are
ifﬁcult to identify by traditional methods in the clinical
icrobiology laboratory and in vitro differences in antifun-
al susceptibility within the genera have been noted. Today,
omparative sequences based methods are considered the
old standards for rapid, accurate and objective species
dentiﬁcation of fungi. Although the rRNA regions includ-
ng the 18S, ITS, 5.8S and D1-D2 hypervariable region of
he 28S have been evaluated as targets, none have proven
o be useful as a ‘‘universal’’ locus for broad fungal iden-
iﬁcation. Recently, fredricks et al., analyzed a hitherto
nexplored region of the 28S rRNA gene for species iden-
iﬁcation of a wide range of fungal genera. In the present
tudy, we explored the utility of this target region for
peciﬁc and discriminatory identiﬁcation of Mucormycota
enera.
Methods: A total of 100 isolates representing 10 differ-
nt medically important genera of Mucormycota from the
ulture collections of the Centers for Disease Control and
revention (CDC), Atlanta, GA, and the National Center for
gricultural Utilization Research, U.S. Department of Agri-
ulture, Peoria, IL were used in this study. Genomic DNA
as extracted using Qiagen kit and PCR ampliﬁcation and
equencing of the extended 28S rRNA was performed as pre-
iously described. Sequences were aligned using Clustal W
nd distance matrices were generated using the Biolomics
oftware.
Results: PCR products were generated for all the isolates
ested and amplicon size differences were detected among
he genera. Accordingly, large regions of insertion/deletion
ere observed when the sequences were aligned. Distance
atrices and phylogenetic analyses revealed appreciable
ucleotide differences among the genera tested.
Conclusion: In summary, the novel 28S r RNA region eval-
ated in this study was readily amenable to PCR/sequencing
nd revealed genus speciﬁc nucleotide differences, thus
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The treatment in the resistant forms has resulted effec-120 14
olding promise as a target for discriminatory genus iden-
iﬁcation of Mucormycota.
oi:10.1016/j.ijid.2010.02.1750
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Background: Recognition of epidemiologi-
al,etiological,topographical and treatment aspects.
n this study are included 45 cases,18-35 yearsold, during
he years 1999—2008 with recurrent (at least 4 episodes
f fungal infections in a year)/resistant (which doesn’t
espond to antifungal therapy) fungal infections.
Methods:We have analyzed the group-ages,the origin and
he immunity state of the patients.We have determined the
tiology,topographic variant of the fungal infections and the
eal sensibility against antifungal drugs (Ketoconazol, Intra-
onazol,Fluconazol,Clotrimazol).
Results: Epidemiologic:
roup-ages Number of cases
8-21 1
2-25 8
6-30 11
1-35 25
Where 28 were citizien, and 17 were peasants.
The immune state:
a) immunocompetent-30 cases
) immune-compromised-15 cases
iagnosis Number of cases
IV 4
olagenosis 4
iabetes Mellitus 2
ymphoma 1
isceral Leishmania 1
ypogamaglobulinemi 1
hyrotoxicosis 1
hronic hepatitis 1
Disease-topographic:Oro-pharyngeal fungal infection-42
ases
opography Number of caseseilitis 6
lositis 9
haryngitis 5
harynx—esophagitis 4
t
7
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Disease-topographic:dermal-16
opography Number of cases
xillary 1
ubmamare 2
nguinal 3
luteal 3
ntradigital 4
Disease-topographic:vulvovaginale -26
opography Number of cases
nal-perianal 2
nicomycosis 2
Etiologic:Candida albicans -33 cases
Candida glabriatra -5 cases
Trichophyton-6 cases
Criptoccocus Laurens-1 case.
Therapeutic:According to mycogram,the clinical
esponse and the subject quality.
-In (19) resistant cases we have:
a) repeated the therapeutic cycle(in 11 cases)
) extended the local treatment(10 cases),
c) associated the systemic treatment(16 cases),
) changed the antifungal drugs(13 cases).
We have done diagnose reconﬁrmation(2 cases from 8 has
esulted misdiagnosed).
3 from 5 cases with candida glabriata were resistand
gainst azole.
-In (26) recurrent cases we have applied the treatment
ith (Fluconazol 100 mg(p.o)or supp.Cotrimazol 500mg 1
ime/week until 6 month)
In 14 cases, after the treatment of recurrent
pisodes(ﬂuconazol 100—200mg/day/7—14 days) we
ave improved the management of immunecompromised
disease of subjects in 13 cases.
Conclusion: The recurrent/resistant fungal infections are
ncountered more frequently in group-ages 31-35 years-
ld,54% of all cases.
33% were immune-compromised;
67% were immune-competent (women).
6% of all cases were named as idiopathic,the long-term
reatment resulted ineffective.
Vulvo-vaginal fungal infections were predominated in
7.7% of cases.
The most frequent etiologic cause was Candida albi-
ans(73.3%).
The resistant fungal infections were 42.2% of all cases;
ecurrent 57.7%.ive in 84.2% and ineffective in 15.7%;in the recurrent forms
3.1% effective and 26.9% ineffective.
oi:10.1016/j.ijid.2010.02.1751
